Genetic Diagnostics Contribute to the Risk Stratification for Major Arrhythmic Events in Pediatric Patients with Long QT Syndrome Type 1–3
- Supplementary File 1:
ZIP-Document (ZIP, 266 KiB)
Burkard, T.; Westphal, D.S.; Markel, F.; Gebauer, R.A.; Hessling, G.; Wolf, C.M. Genetic Diagnostics Contribute to the Risk Stratification for Major Arrhythmic Events in Pediatric Patients with Long QT Syndrome Type 1–3. Cardiogenetics 2022, 12, 90-101. https://doi.org/10.3390/cardiogenetics12010009
Burkard T, Westphal DS, Markel F, Gebauer RA, Hessling G, Wolf CM. Genetic Diagnostics Contribute to the Risk Stratification for Major Arrhythmic Events in Pediatric Patients with Long QT Syndrome Type 1–3. Cardiogenetics. 2022; 12(1):90-101. https://doi.org/10.3390/cardiogenetics12010009
Chicago/Turabian StyleBurkard, Tobias, Dominik S. Westphal, Franziska Markel, Roman A. Gebauer, Gabriele Hessling, and Cordula M. Wolf. 2022. "Genetic Diagnostics Contribute to the Risk Stratification for Major Arrhythmic Events in Pediatric Patients with Long QT Syndrome Type 1–3" Cardiogenetics 12, no. 1: 90-101. https://doi.org/10.3390/cardiogenetics12010009